NCT02455427View on ClinicalTrials.gov

Safety of Transcranial Direct Current Stimulation in the Subacute Phase After Stroke

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Stroke
Interventions
DEVICE

Active tDCS

Active tDCS will be applied with the anode positioned over the ipsilesional primary motor cortex and the cathode over the contralateral supraorbital region for 20 minutes (1mA).

OTHER

Physical Therapy

Physical therapy will be administered for 60 minutes

DEVICE

Sham tDCS

In sham tDCS, no current will be delivered through the tDCS device.

Trial Locations (1)

05652-901

Danielle Boasquevisque, São Paulo

All Listed Sponsors
lead

Hospital Israelita Albert Einstein

OTHER

NCT02455427 - Safety of Transcranial Direct Current Stimulation in the Subacute Phase After Stroke | Biotech Hunter | Biotech Hunter